Combination of UGT1A1 polymorphism and baseline plasma bilirubin levels in predicting the risk of antipsychotic-induced dyslipidemia in schizophrenia patients
Article in Schizophrenia (May 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Schizophrenia (May 2024)
Article in Clinical Psychopharmacology and Neuroscience (February 2023)
Article in Schizophrenia Bulletin (May 2022)